The long-term mission of the Mayo Clinic Comprehensive Metabolomics Research Core (MCCMRC) is to facilitate access to metabolomic techniques for use in both basic and disease-oriented research while continuously developing novel methodologies designed to better understand the metabolic derangements present in disease. The Core will also enhance awareness of and education on the potential application of metabolomics tools in research. The administrative core of MCCMRC is intended to help create and foster such an interactive and productive environment and will take advantage of Mayo's unique strengths and track record in metabolic research including an established Metabolomics Core and multiple investigators with extramural funding for research programs based on metabolomic techniques. The Core is strengthened by integration of the NMRS facility to the Metabolomics Core enhancing the availability of advanced mass spectrometry techniques. The MCCMRC's global efforts will be enhanced by substantial institutional resources including a Center for Translational Science Activities (CTSA) grant and complementary institutional cores. Ultimately, the MCCMRC will enhance and expand the collaborative intersections and critical mass of scientists utilizing metabolomic techniques in disease-oriented research. The administrative core will be the link between the Metabolomics Core, Mayo Clinic Leadership and National Consortium leadership. The administrative core will help to achieve the goals of the MCCMRC by coordinating the goals set by the program director in consultation with the internal and external advisory committees. Moreover, the administrative core will oversee the hiring and training of additional staff, installation of additional equipment, establishing techniques and quality control measures. It will facilitate the activities of the Promotion and Outreach core which will include developing course work for new investigators and a Request For Applications for pilot and feasibility projects. It is anticipated that the new services will be available in years 2-3. Years 4-5 will be focused on outreach efforts to expand the investigator pool. By the end of the 5 year period we will transition to a self-sustaining model through the implementation of a fee-for-service cost recovery model. This process will be guided and supported through the administrative infrastructure in place to support core billing and compliance. In addition, the administrative core will oversee and prioritize requests for resource sharing both intramurally and extramurally.

Public Health Relevance

This proposal is prepared in response to RFA-RM-11-016: Regional Comprehensive Metabolomics Resource Cores (RCMRC) (U24). The administrative core will oversee this initiative and facilitate the transition to a self-sustaining model for funding ensuring the long term success of the Mayo Clinic Comprehensive Metabolomics Research Core (MCCMRC) and its stated goals.

Project Start
Project End
Budget Start
2014-09-01
Budget End
2015-08-31
Support Year
2
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
City
Rochester
State
MN
Country
United States
Zip Code
55905
Smestad, John; Erber, Luke; Chen, Yue et al. (2018) Chromatin Succinylation Correlates with Active Gene Expression and Is Perturbed by Defective TCA Cycle Metabolism. iScience 2:63-75
Hale, Vanessa L; Jeraldo, Patricio; Mundy, Michael et al. (2018) Synthesis of multi-omic data and community metabolic models reveals insights into the role of hydrogen sulfide in colon cancer. Methods 149:59-68
Fukushima, Masanori; Dasgupta, Debanjali; Mauer, Amy S et al. (2018) StAR-related lipid transfer domain 11 (STARD11)-mediated ceramide transport mediates extracellular vesicle biogenesis. J Biol Chem 293:15277-15289
Robinson, Matthew M; Lowe, Val J; Nair, K Sreekumaran (2018) Increased Brain Glucose Uptake After 12 Weeks of Aerobic High-Intensity Interval Training in Young and Older Adults. J Clin Endocrinol Metab 103:221-227
Smestad, John; Hamidi, Oksana; Wang, Lin et al. (2018) Characterization and metabolic synthetic lethal testing in a new model of SDH-loss familial pheochromocytoma and paraganglioma. Oncotarget 9:6109-6127
Lee, Sunhye; Keirsey, Katherine I; Kirkland, Rebecca et al. (2018) Blueberry Supplementation Influences the Gut Microbiota, Inflammation, and Insulin Resistance in High-Fat-Diet-Fed Rats. J Nutr 148:209-219
Tran, Lee; Kras, Katon A; Hoffman, Nyssa et al. (2018) Lower Fasted-State but Greater Increase in Muscle Protein Synthesis in Response to Elevated Plasma Amino Acids in Obesity. Obesity (Silver Spring) 26:1179-1187
Pak, Victoria M; Dai, Feng; Keenan, Brendan T et al. (2018) Lower plasma choline levels are associated with sleepiness symptoms. Sleep Med 44:89-96
Luthra, Gauri; Vuckovic, Ivan; Bangdiwala, A et al. (2018) First and second trimester urinary metabolic profiles and fetal growth restriction: an exploratory nested case-control study within the infant development and environment study. BMC Pregnancy Childbirth 18:48
Chang, Alice Y; Lalia, Antigoni Z; Jenkins, Gregory D et al. (2017) Combining a nontargeted and targeted metabolomics approach to identify metabolic pathways significantly altered in polycystic ovary syndrome. Metabolism 71:52-63

Showing the most recent 10 out of 88 publications